Literature DB >> 6214500

Antigenic competition in IgE antibody production. II. Effect of cyclophosphamide.

M S de Macedo, I Mota.   

Abstract

The effects of cyclophosphamide (CY) on antigenic competition in IgE antibody production were studied in mice treated with the drug on different days and immunized with a mixture of two non-related antigens. Injection of 100 mg of CY/kg of body weight 3 days before or 6 days after immunization resulted in a partial or total recovery of the IgE, but not of the IgGl antibody response to the test antigen. In contrast, when the same dose was given together or 3 days after immunization both responses were much more suppressed than in untreated animals. This same effect was obtained when a higher concentration (200 mg/kg) of cyclophosphamide was injected on day--3. When a different antigenic system was tested, the suppressive effects of competition in IgGl antibody production were also abolished after CY treatment. These results seem to provide further evidence for an important role of suppressor T cells in the mechanism of antigenic competition.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6214500      PMCID: PMC1555528     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  Hapten-specific IgE antibody responses in mice. VI. Selective enhancement of IgE antibody production by low doses of X-irradiation and by cyclophosphamide.

Authors:  N Chiorazzi; D A Fox; D H Katz
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

2.  Control of IgE and IgG1 antibody production in mice.

Authors:  M S de Macedo; F Braga; I Mota
Journal:  Cell Immunol       Date:  1976-05       Impact factor: 4.868

3.  Regulation of homocytotropic antibody formation in the rat. IV. Effects of various immunosuppressive drugs.

Authors:  M Taniguchi; T Tada
Journal:  J Immunol       Date:  1971-08       Impact factor: 5.422

4.  Regulation of homocytotropic antibody formation in the rat. II. Effect of X-irradiation.

Authors:  T Tada; M Taniguchi; K Okumura
Journal:  J Immunol       Date:  1971-04       Impact factor: 5.422

5.  Reversal of immunological tolerance by cyclophosphamide through inhibition of suppressor cell activity.

Authors:  L Polak; J L Turk
Journal:  Nature       Date:  1974-06-14       Impact factor: 49.962

6.  Differential effects of cyclophosphamide on the B and T cell compartments of adult mice.

Authors:  G D Stockman; L R Heim; M A South; J J Trentin
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

7.  Selective depletion of lymphoid tissue by cyclophosphamide.

Authors:  J L Turk; L W Poulter
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

8.  Homologous and heterologous passive cutaneous anaphylactic activity of mouse antisera during the course of immunization.

Authors:  I Mota; D Wong
Journal:  Life Sci       Date:  1969-08-15       Impact factor: 5.037

9.  Genetic control of specific immune suppression. IV. Responsiveness to the random copolymer L-glutamic acid50-L-tyrosine50 induced in BALB/c mice by cyclophosphamide.

Authors:  P Debré; C Waltenbaugh; M E Dorf; B Benacerraf
Journal:  J Exp Med       Date:  1976-07-01       Impact factor: 14.307

10.  Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.

Authors:  P W Askenase; B J Hayden; R K Gershon
Journal:  J Exp Med       Date:  1975-03-01       Impact factor: 14.307

View more
  1 in total

1.  Absence of suppression in natural and induced tolerance to F antigen.

Authors:  N B Nardi
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.